Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome

Table 2 Laboratory characteristics of patients with nonalcoholic fatty liver disease and of those without nonalcoholic fatty liver disease

	Patients with NAFLD(n = 32)	Patients without NAFLD(n = 383)	P value
Glucose (mg/dL)	125 ± 64	113 ± 46	NS
LDL-C (mg/dL)	112 ± 42	112 ± 40	NS
HDL-C (mg/dL)	39 ± 12	47 ± 15	<0.05
Triglycerides (mg/dL)	144 ± 65	119 ± 51	<0.05
Uric acid (mg/dL)	5.6 ± 1.8	5.7 ± 1.8	NS
eGFR (mL/min/1.73 m2)	65 ± 19	69 ± 23	NS
Alanine aminotransferase (U/L)	35 ± 21	17 ± 13	<0.001
Aspartate aminotransferase (U/L)	56 ± 23	23 ± 17	<0.001
γ-glutamyl transpeptidase (U/L)	38 ± 29	24 ± 31	<0.05
Alkaline phosphatase (U/L)	71 ± 24	71 ± 32	NS
Total bilirubin (mg/dL)	0.83 ± 0.46	0.77 ± 0.48	NS
Direct bilirubin (mg/dL)	0.30 ± 0.19	0.28 ± 0.28	NS
Creatine kinase (U/L)	91 ± 40	119 ± 197	NS

LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; eGFR: Estimated glomerular filtration rate; NS: Not significant; NAFLD: Nonalcoholic fatty liver disease.